Cimzia is a medicine used to treat certain types of arthritis, like rheumatoid arthritis and psoriatic arthritis. It works by blocking a substance called TNF-alpha, which helps reduce inflammation and pain in the joints. It's taken as an injection.
Every report comes from a Lived member, sent anonymously.
Have you tried Cimzia (Certolizumab Pegol) for Rheumatoid Arthritis?
Certolizumab pegol, sold as Cimzia, is an injectable biologic medicine that calms certain kinds of long-term inflammation. It belongs to a group of medicines called tumor necrosis factor (TNF) blockers. In the US it is approved for adults with moderately to severely active rheumatoid arthritis, active psoriatic arthritis, active ankylosing spondylitis, and non-radiographic axial spondyloarthritis (inflammatory back and spine disease that does not yet show damage on X-rays but has objective signs of inflammation, such as on a magnetic resonance imaging (MRI) scan or a blood test). It is also approved for adults with moderate to severe plaque psoriasis who are candidates for whole-body treatment or light therapy, and for adults with moderately to severely active Crohn's disease who have not done well enough on conventional treatment. Children 2 and older can receive it for polyarticular juvenile idiopathic arthritis, a form of childhood arthritis that affects many joints. It is usually considered when standard treatments, such as methotrexate for arthritis or conventional therapy for Crohn's disease, have not controlled the disease well enough, or when the disease is active enough to need a biologic.
TNF is a signaling protein the immune system uses to start and sustain inflammation. In conditions such as rheumatoid arthritis, psoriasis and Crohn's disease, the body makes too much of it, which helps drive ongoing joint swelling, skin plaques or gut inflammation. Certolizumab is a piece of a lab-made antibody that latches onto TNF and neutralizes it, so less of that inflammatory signal reaches cells. It is only part of an antibody, without the tail section a complete antibody carries, and it is attached to polyethylene glycol, a chemical chain that gives it the "pegol" in its name. Because TNF also helps the body fight infections, blocking it is what makes infection the main trade-off of this medicine.
Cimzia is injected under the skin of the thigh or abdomen. It comes as a 200 mg prefilled syringe that people can learn to inject at home, and as a powder that a health care professional mixes and injects in a clinic. Treatment usually begins with a larger starting dose (two injections) at weeks 0, 2 and 4. After that, depending on the condition, people continue with one injection every two weeks or two injections every four weeks. Plaque psoriasis often uses a higher ongoing dose. Children's doses depend on weight, and doses below 200 mg must be given by a health care professional using the vial kit. The syringes are kept in the refrigerator and allowed to warm to room temperature before injecting. If needed, they can stay at room temperature in their carton for up to seven days, but should not go back in the refrigerator. Rotate injection sites, keep each new site at least an inch from the last one, and avoid skin that is tender, bruised, red, hard or scarred. Do not use a syringe if the liquid is cloudy or has particles in it.
The most common side effects are colds and other upper respiratory infections, rash and urinary tract infections. Redness, swelling or discomfort where the injection was given can also happen. Because Cimzia lowers the immune system's ability to fight infection, contact the care team promptly about fever, a cough that will not go away, night sweats, unexplained weight loss, burning with urination or any infection that seems to be getting worse. Also contact the care team promptly about unusual bruising or bleeding or looking very pale, which can rarely signal low blood counts. A few rarer problems have recognizable signs worth reporting. New shortness of breath or ankle swelling can mean heart failure is starting or getting worse. Numbness, tingling or vision changes can signal a nerve condition such as multiple sclerosis. A rash on the cheeks or arms that worsens in the sun, especially with joint pain, can signal a lupus-like reaction. Serious allergic reactions are rare but can follow even the first dose. Call 911 for swelling of the face, lips or throat, trouble breathing, or feeling faint after an injection. The needle cap of the prefilled syringe contains a derivative of natural rubber latex, so people with a latex allergy should tell their prescriber.
Cimzia carries the US Food and Drug Administration's most serious type of warning for two risks. The first is serious infection, including tuberculosis (TB), fungal infections and other unusual infections that can lead to hospitalization or death. Most people who developed these were also taking other immune-suppressing medicines such as methotrexate or steroids, and the risk is higher in people over 65 or with other health conditions. Everyone is tested for latent (hidden) TB before starting, and anyone who tests positive is treated for it first; the care team keeps watching for TB during treatment even after a negative test. Cimzia is not started while someone has an active infection, and it should not be used by anyone who has had a serious allergic reaction to it. The second is cancer: lymphoma (a cancer of immune cells) and other cancers, some fatal, have been reported in children and teenagers taking TNF blockers. Researchers have also seen lymphoma in adults, though people with highly active rheumatoid arthritis or Crohn's disease already have a higher baseline risk. Skin cancers have also been reported, so periodic skin checks are advised, especially for people with risk factors for skin cancer. People are also tested for hepatitis B before starting, because TNF blockers can reawaken a hidden hepatitis B infection. Cimzia is not recommended in combination with other biologic immune treatments such as abatacept, rituximab, anakinra or natalizumab, because the combination raises infection risk without clear added benefit. Cimzia can also falsely raise some results of a blood clotting test called the activated partial thromboplastin time (aPTT), so mention it before clotting tests. Vaccines are best brought up to date before treatment. Live vaccines, which contain a weakened form of a germ, should be avoided during treatment and just before starting. TNF blockers can worsen heart failure or, rarely, trigger nerve conditions such as multiple sclerosis, so people with either history should discuss this before starting. In pregnancy, studies found little or no Cimzia in most newborns' blood at birth, and only small amounts pass into breast milk, but there is not enough data to fully settle its safety in pregnancy. Uncontrolled arthritis or Crohn's disease also carries risks for a pregnancy, so plans are best discussed early. If Cimzia was used during pregnancy, the baby's doctor should know before any live vaccines.
Before the first dose, expect blood tests and a TB test, and a review of vaccines and any infections. For Crohn's disease, the prescriber usually checks response after the three starting doses, at about six weeks, and treatment continues only if it is helping. For psoriasis, skin improvement is typically judged at around 12 to 16 weeks. For arthritis and spine conditions, the prescriber will usually judge over the first few months whether symptoms and inflammation are improving enough. Not everyone responds. If Cimzia does not help enough, the prescriber can discuss other treatments, including medicines that work on a different part of the immune system. For people who do respond, Cimzia is usually continued to keep inflammation under control rather than to cure the condition. Ongoing visits and lab tests check how well it is working and watch for infections and other side effects. Tell any surgeon or dentist that you use Cimzia before a procedure, and if a dose is missed, follow the prescriber's instructions rather than doubling up.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share your experience taking Cimzia (Certolizumab Pegol), what you've noticed, or ask the community a question.